Emiko Urano
3 Papers
14 Citations
Emiko Urano is an academic researcher. The author has contributed to research in topics: Internal medicine & Adipose tissue. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaques
Takahiro Nagatake,Shigenobu Kishino,Emiko Urano,T. Murakami,Nahoko Kitamura,Kana Konishi,Harumi Ohno,Prabhakar Singh Tiwari,Sakiko Morimoto,Eri Node,Jun Adachi,Yuichi Abe,Junko Isoyama,Kento Sawane,Tetsuya Honda,Asuka Inoue,Akiharu Uwamizu,Takashi Matsuzaka,Yoichi Miyamoto,Soichiro Hirata,Azusa Saika,Yuki Shibata,Koji Hosomi,Ayu Matsunaga,Hitoshi Shimano,Makoto Arita,Junken Aoki,Masahiro Oka,Akira Matsutani,Takeshi Tomonaga,Kenji Kabashima,Motohiko Miyachi,Yasuhiro Yasutomi,Jun Ogawa,Jun Kunisawa +34 more
TL;DR: In this paper , the authors demonstrate that microbiota play an essential role in the body's use of dietary lipids for the control of inflammatory diseases and demonstrate that αKetoA is a novel postbiotic derived from α-linolenic acid, which may have potential for developing therapeutic drugs as well as probiotic food products.
14
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Emiko Urano,Yumi Ito,Tatsuya Suzuki,Takanori Sasaki,Jun-ichi Kishikawa,Kanako Akamatsu,Yusuke Higuchi,Yusuke Sakai,Tomotaka Okamura,Shuya Mitoma,Fuminori Sugihara,Akira Takada,Mari Kimura,Shuto Nakao,Mika Hirose,Tadahiro Sasaki,Ritsuko Koketsu,Shunya Tsuji,S. Yanagida,Tatsuo Shioda,Eiji Hara,Satoaki Matoba,Yoshiharu Matsuura,Yasunari Kanda,Hisashi Arase,Masato Okada,Junichi Takagi,Takayuki Kato,Atsushi Hoshino,Yasuhiro Yasutomi,Akatsuki Saito,Toru Okamoto +31 more
TL;DR: The results indicate that this engineered ACE2 decoy represents a promising therapeutic strategy to overcome immune-evading SARS-CoV-2 variants and that liquid aerosol inhalation could be considered as a noninvasive approach to enhance the efficacy of COVID-19 treatments.
12
Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaques
Takahiro Nagatake,Shigenobu Kishino,Emiko Urano,T. Murakami,Nahoko Kitamura,Kana Konishi,Harumi Ohno,Prabhakar Singh Tiwari,Sakiko Morimoto,Eri Node,Jun Adachi,Yuichi Abe,Junko Isoyama,Kento Sawane,Tetsuya Honda,Asuka Inoue,Akiharu Uwamizu,Takashi Matsuzaka,Yoichi Miyamoto,Soichiro Hirata,Azusa Saika,Yuki Shibata,Koji Hosomi,Ayu Matsunaga,Hitoshi Shimano,Makoto Arita,Junken Aoki,Masahiro Oka,Akira Matsutani,Takeshi Tomonaga,Kenji Kabashima,Motohiko Miyachi,Yasuhiro Yasutomi,Jun Ogawa,Jun Kunisawa +34 more
TL;DR: In this paper , the authors demonstrate that microbiota play an essential role in the body's use of dietary lipids for the control of inflammatory diseases and demonstrate that αKetoA is a novel postbiotic derived from α-linolenic acid, which may have potential for developing therapeutic drugs as well as probiotic food products.